Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Effect of dabrafenib on melanoma cell lines harbouring the BRAF V600D/R mutations

  • Giusy Gentilcore1,
  • Gabriele Madonna1,
  • Nicola Mozzillo1,
  • Antoni Ribas2,
  • Antonio Cossu3,
  • Giuseppe Palmieri4 and
  • Paolo A Ascierto1, 5Email author
BMC Cancer201313:17

DOI: 10.1186/1471-2407-13-17

Received: 25 March 2012

Accepted: 13 November 2012

Published: 14 January 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
25 Mar 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
21 May 2012 Author responded Author comments - Paolo A. Ascierto
Resubmission - Version 3
21 May 2012 Submitted Manuscript version 3
1 Aug 2012 Reviewed Reviewer Report - Richard Kefford
5 Oct 2012 Reviewed Reviewer Report - Michael Davies
31 Oct 2012 Author responded Author comments - Paolo A. Ascierto
Resubmission - Version 4
31 Oct 2012 Submitted Manuscript version 4
Publishing
13 Nov 2012 Editorially accepted
14 Jan 2013 Article published 10.1186/1471-2407-13-17

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department Melanoma, Istituto Nazionale Tumori Fondazione Pascale
(2)
Department of Medicine, Jonsson Comprehensive Cancer Center, UCLA
(3)
Department of Pathology, Hospital-University Health Unit (AOU)
(4)
Institute of Biomolecular Chemistry, National Research Council (ICB-CNR)
(5)
Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori “Fondazione G. Pascale”, Via Mariano Semmola

Advertisement